Kunshan RiboQuark Pharmaceutical Technology

China
Kunshan, Jiangsu, China

Company profile

Kunshan RiboQuark Pharmaceutical Technology company profile

Kunshan RiboQuark Pharmaceutical Technology Co., Ltd. develops siRNA based preclinical drug candidates. Its products include QPI-1007, an ocular neuroprotectant. The company also develops siRNA-based cosmetic product for the prevention of hair loss. The company was founded in 2012 and is based in Kunshan, China.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2012-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$7.4M
Last funding
Series A / $7.4M / 2014-01-08
Last equity funding
Series A / $7.4M
Investors
1
Lead investors
1
Founders
1

Founders and investors

Founders

Daniel Zurr

Lead investors

BVCF

Investors

BVCF